Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesUrologyAetna urological supplies coverage update | OpenPa…
    Ask Trek AI about this page
    CurrentAetnaPolicy 0533

    Urological supplies (catheters and external urinary collection devices)

    Customize your policy alerts

    Sign up for Aetna Policy 0533 alerts

    Get alerted when Policy 0533 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    Defines medical necessity, coverage, quantity limits, documentation and supplier requirements for urinary catheters, intermittent catheterization kits, external urinary collection devices, irrigation supplies, and related accessories for Aetna members.

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Policy Summary
    PayerAetna
    PolicyUrological supplies (catheters and external urinary collection devices)
    Policy CodePolicy 0533
    Change TypeRoutine review — no material changes
    Effective DateAug 21, 2001
    Last ReviewJun 10, 2027
    Next Review DateJun 10, 2027
    Key ActionProvide a completed Standard Written Order (SWO) to the supplier before submitting a claim.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    1/moroutine catheter allowance
    200max intermittent catheters/packets
    35/momax male external catheters
    29dinFlow replacement interval
    multiplecode lists included
    07/30/2026last review

    Coverage Criteria for Urological Supplies

    inv-01: General medical necessity for catheters and external devices

    Covered when ALL of the following are met:

    base_criteria: Member has permanent urinary incontinence or permanent urinary retention (retention not expected to be medically or surgically corrected within 3 months).

    The term 'external urinary collection devices' includes male external catheters and female pouches or meatal cups and does not include diapers or other absorptive pads.

    inv-02: Routine catheter supply frequency

    Covered when ALL of the following are met:

    routine_catheter: One catheter per month is medically necessary for routine catheter maintenance. Non-routine catheter changes are medically necessary only for exceptional circumstances such as accidental removal; catheter obstruction from encrustation, mucous plug, or blood clot; catheter malfunction (e.g., balloon failure or hole); or established history of recurrent obstruction or UTI for which scheduled changes at intervals <1 month prevent acute events.1 per month

    TuckSpecialty and all-silicone catheters are medically necessary when straight Foley with coating cannot be used; Coude tip catheters in females are rarely necessary. One insertion tray is medically necessary per episode of indwelling catheter insertion.

    inv-03: Intermittent sterile catheterization

    Sterile intermittent catheterization is covered when the member requires catheterization AND ANY of the following apply:

    sterile_intermit_criteria: Member resides in a nursing facility; OR member is immunosuppressed (examples: AIDS; chronic oral corticosteroid use; on post-transplant immunosuppressive regimen; receiving cancer chemotherapy); OR radiologically documented vesico-ureteral reflux while on a program of intermittent catheterization; OR spinal cord–injured female who is pregnant (coverage for duration of pregnancy only); OR distinct recurrent urinary tract infections while on clean intermittent catheterization (defined as two infections within 12 months).

    Sterile intermittent catheterization uses a new sterile packaged catheter and sterile lubricant for each catheterization; may include sterile gloves, drape, and antiseptic peri-urethral cleansing. UTI is defined per policy (e.g., urine culture >10,000 CFU plus clinical signs/symptoms).

    inv-04: Male external catheters / female external devices

    Covered when ALL of the following are met:

    external_devices: Male external catheters or female external urinary collection devices are medically necessary for members with permanent urinary incontinence when used as an alternative to an indwelling catheter. They are not medically necessary when ordered for members who also use an indwelling catheter.male: generally ≤35 per month; female: ≤1 meatal cup/week or ≤1 pouch/day

    Adhesive strips or tape used with male external catheters are included in the code allowance; specialty-type male external catheters (e.g., inflatable or with faceplate) are covered when clinically justified. PureWick system is considered unproven and not medically necessary.

    inv-05: inFlow device

    Covered when ALL of the following are met:

    inFlow_coverage: Patient is a woman with permanent urinary retention due to impaired detrusor contractility and inFlow is being used as an alternative to intermittent catheterization; device sizing and initial insertion are performed by a physician.one device no more than once every 29 days

    Continued medical necessity beyond the first 3 months requires a treating practitioner re-evaluation between day 31 and day 91 documenting an in-person encounter with symptom improvement and verification of adherence; if not met, continued use is not medically necessary. Device replacement interval is every 29 days.

    inv-06: Irrigation supplies

    Covered when ALL of the following are met:

    nonroutine_irrigation: Supplies for intermittent (as‑needed) catheter irrigation (irrigation tray or irrigation syringe and sterile saline/sterile water) are medically necessary when used for acute catheter obstruction (e.g., encrustation, clot). Routine irrigation supplies/syringes used for routine irrigation are not medically necessary. Supplies for continuous irrigation (3‑way Foley and irrigation tubing set with sterile saline/water) are medically necessary only when history of catheter obstruction exists and patency cannot be maintained by intermittent irrigation and catheter changes; continuous irrigation >2 weeks is rarely medically necessary.A4355: max 1 per day up to 2 weeks

    More than one irrigation tubing set per day is not medically necessary; irrigation supplies used for skin/perineum care are not covered.

    inv-07: Items requiring specific selection criteria

    Covered when ALL of the following selection criteria are met (per-item details referenced below):

    Selection criteria for specialized supplies: Certain items (for example: three-way Foley catheters for continuous irrigation A4346; irrigation tubing sets A4355; inFlow device CPT 0596T/0597T and HCPCS A4341/A4342; ureteral stents C1875/C2617) are covered only when the documented clinical indication meets the policy’s selection criteria (eg, retention, neuromuscular bladder dysfunction, or documented need for continuous irrigation).see ICD-10 codes and duration expectations

    Specific per-item inclusions, exclusions and per-code quantity limits apply as listed in the coding and limitations sections.

    inv-08: Quantity limits

    Coverage limited by per-item frequency/quantity limits consistent with DME MAC policy:

    DME MAC quantity limits: Examples of limits include: insertion trays with drainage bag and specified indwelling Foley types limited to 1 per month for listed items; bedside drainage bags limited to 2 per month; urinary leg bags and selected bedside bottles/containers have specified monthly/quarterly limits; intermittent catheters and lubricant packets limited to 200 per month; irrigation tubing set A4355 limited to 1 per day up to 2 weeks.intermittent catheters/lubricant packets: 200/month; insertion trays: 1/month (selected types); bedside drainage bag: 2/month; A4355: 1/day up to 2 weeks

    Either vinyl or latex leg bags allowed but not both; some items include accessories within their allowance (see coding table).

    inv-09: inFlow device coverage

    Covered when ALL of the following are met:

    Indication: Patient is a woman with permanently impaired detrusor contractility or underactive bladder resulting in inability to empty the bladder (eg, neurologic origin).

    Document diagnosis consistent with policy (eg, N32.81, R33.x).

    Prior therapy/trial: Selection criteria include documentation of prior management such as trial of clean intermittent catheterization (CIC) and tolerability where applicable. Clinical records should document prior therapies and tolerability trials when relevant.

    Therapy sequencing and prior trial documentation may be required for review.

    Device sizing/insertion: Device sizing and initial insertion performed by a physician; device replacement every 29 days as specified. CPT 0596T for initial insertion and 0597T for replacement apply when selection criteria are met.replace every 29 days

    Re-evaluation between day 31 and day 91 required to continue coverage beyond 3 months.

    inv-10: Female external urine wicking devices (PureWick/Tibbe) coverage

    Covered when ALL of the following are met:

    Indication: Patient requires a noninvasive external female urine collection/management strategy to manage urinary incontinence or to reduce reliance on indwelling catheters (eg, nocturnal incontinence in the home setting).

    Document clinical rationale and intended use environment (eg, home nocturnal use) and confirm member is not concurrently using an indwelling catheter.

    Implementation: Use within a structured deployment protocol, including caregiver training and monitoring, is recommended as it may be necessary to achieve reductions in catheter utilization and infection rates.

    Document protocols, caregiver education, and implementation fidelity where applicable.

    Evidence considerations: Randomized and nonrandomized evidence exist (eg, PureWick randomized trial and systematic review/meta-analysis) showing potential to reduce indwelling catheter use and acceptable urine capture/skin outcomes; however evidence quality and implementation variability should be considered when approving coverage. Tibbe has less peer‑reviewed evidence. PureWick trial achieved noninferiority for urine capture and skin irritation in a 165‑patient randomized trial.

    inv-11: Absorbable urologic scaffold (Voro) — intraoperative implantation during RARP

    Investigational/coverage stance and criteria:

    Current evidence: Early feasibility single-arm data (ARID study) report favorable early continence outcomes after intraoperative implantation of an absorbable urologic scaffold during RARP (eg, n=24 evaluable) but the evidence is limited by small sample size, single-arm design, short follow-up, and lack of randomized controlled data. These limitations preclude definitive conclusions about effectiveness and durability.

    If considered for coverage, documentation should include intraoperative placement technique and detailed follow-up; outcomes vary substantially with optimal versus suboptimal placement.

    Placement importance: Outcomes appear highly dependent on optimal scaffold placement; suboptimal placement is associated with markedly poorer results.

    Document intraoperative technique and placement quality if device use is reported in the medical record.

    Items that are not covered (except when supplied as part of a home health visit) include non‑prosthetic incontinence and ancillary items that are not required for use of a urinary catheter or external urinary collection device. Examples include: adhesive remover; catheter care kits; catheter clamp or plug; creams, salves, lotions, barriers (liquid, spray, wipes, powder, paste); diapers, drip collectors, or incontinent garments (disposable or reusable); disposable underpads; drainage bag holder or stand; gauze pads and other dressings (may be covered under other benefits); measuring containers; urinary drainage trays; urinary suspensory without leg bag; and other incontinence products not directly related to the use of a medically necessary urinary catheter or external urinary collection device. Non‑medical items such as rubber bands, rubber gloves, scissors, and sheets are also not covered.

    The policy states that the PureWick urine collection system is considered unproven and not medically necessary for the management of urinary incontinence.

    Specific HCPCS codes and supply items are listed as not covered for indications in this Clinical Policy Bulletin. Examples include codes for alcohol wipes and povidone/Betadine swabs (e.g., A4245, A4247), therapeutic irrigation agents (e.g., A4321), miscellaneous incontinence supplies and non‑covered accessory kits (A4335), and irrigation solutions containing antibiotics or chemotherapeutic agents (A9270). These listed items may be denied when billed for excluded indications.

    Catheter insertion trays and certain insertion supplies are not medically necessary for routine clean intermittent catheterization (CIC). The policy indicates insertion trays (codes such as A4310–A4316) are included in the coding appendix with notes that they are not medically necessary for CIC and are limited by per‑month maximums when used with indwelling catheters.

    The individual sterile lubricant packet (HCPCS A4332) is explicitly identified in the policy as not medically necessary for clean intermittent catheterization (CIC) and therefore excluded for that indication.

    Use of the sterile individual lubricant packet (A4332) for CIC is specifically noted as not medically necessary, and claims for this supply billed for CIC may be denied.

    This Clinical Policy Bulletin provides a general description of covered benefits and administrative guidance but does not constitute a contract and does not guarantee coverage. Providers must document medical necessity in the member’s medical record; supplier‑prepared statements or attestations alone are insufficient, and a new prescription is required each time a new device or repair is requested.

    Catheter insertion trays are stated to be of no proven benefit when used for clean, non‑sterile intermittent catheterization. The policy also clarifies that routine intermittent irrigation supplies and routine scheduled irrigations are not medically necessary; irrigation supplies are medically necessary only when used on an as‑needed basis for acute catheter obstruction or when continuous irrigation is indicated under the specific criteria described.

    Male external catheters and female external urinary collection devices are considered alternatives to indwelling catheters for members with permanent urinary incontinence, but they are not medically necessary when ordered for members who also use an indwelling catheter.

    Catheter/tube anchoring devices used to secure indwelling urethral catheters are generally not medically necessary. Anchoring devices are considered medically necessary to secure covered suprapubic tubes or nephrostomy tubes, but a catheter/tube anchoring device is not considered necessary solely to anchor an indwelling urethral catheter.

    The policy designates certain accessories and insertion trays as not medically necessary for clean intermittent catheterization (CIC) or otherwise limited by frequency. Examples referenced in the coding appendix include insertion tray codes (A4310–A4316), accessory and anchoring codes (e.g., A4331, A4332), and other listed supply codes that either are included in tray allowances or are explicitly excluded for CIC.

    The policy reiterates that the single‑use sterile lubricant packet (A4332) is not medically necessary for CIC. For clean intermittent catheterization the allowance is focused on non‑sterile lubricating gel (limit: maximum 8 ounces per month), and sterile packets should not be billed for CIC.

    Coding: HCPCS, CPT, and Diagnosis Codes

    HCPCS/CPT/Other codes listedmixed
    1042TNew Implantation of absorbable urologic scaffold for prosthetic urethra restoration of reconstructed bladder neck and urethral anastomosis (List separately in addition to code for primary procedure).
    A4295Intermittent urinary catheter; straight tip, hydrophilic coating, each.
    A4296Intermittent urinary catheter; coude (curved) tip, hydrophilic coating, each.
    A4297Hydrophilic coating, with insertion supplies.
    A4310Insertion tray without drainage bag and without catheter (accessories only).
    A4311Insertion tray without drainage bag with indwelling catheter, Foley type, two-way latex with coating.
    A4312Insertion tray without drainage bag with indwelling catheter, Foley type, two-way, all silicone.
    A4313Insertion tray without drainage bag with indwelling catheter, Foley type, three-way, for continuous irrigation.
    A4314Insertion tray with drainage bag with indwelling catheter, Foley type, two-way latex with coating.
    A4315Insertion tray with drainage bag with indwelling catheter, Foley type, two-way, all silicone.
    1–10 of 60
    1/6
    ICD-10 diagnoses covered if selection criteria are metICD-10Covered
    N31.0 - N31.9Neuromuscular dysfunction of bladder, not elsewhere classified.
    N32.81Overactive bladder [impaired detrusor contractility].
    N32.89Other specified disorders of bladder.
    N39.3 - N39.498Stress and other specified urinary incontinence [expected to be 3 months duration or more].
    R32Unspecified urinary incontinence [expected to be 3 months duration or more].
    R33.0 - R33.9Retention of urine [expected to be 3 months duration or more].
    R39.14Feeling of incomplete bladder emptying.
    Supply HCPCS codes (selected)HCPCSCovered
    A4217Sterile water/saline, 500 ml [for as needed/non-routine irrigation].
    A4320Irrigation tray with bulb or piston syringe, any purpose [as needed/non-routine basis].
    A4322Irrigation syringe, bulb or piston, each [as needed/non-routine basis].
    A4332Lubricant, individual sterile packet, each [not medically necessary for CIC].
    A4402Lubricant, per oz. [maximum 8 ounces of non-sterile lubricating gel per month for CIC].
    A4450Tape, non-waterproof, per 18 square inches [included with male external catheters] [maximum 5 yards per month].
    A4452Tape, waterproof, per 18 square inches [included with male external catheters] [maximum 5 yards per month].
    inFlow / intraurethral valve-pump codesCPT|HCPCSCovered
    0596TTemporary female intraurethral valve-pump (ie, voiding prosthesis); initial insertion, including urethral measurement.
    0597TTemporary female intraurethral valve-pump (ie, voiding prosthesis); replacement.
    A4341Indwelling intraurethral drainage device with valve, patient inserted, replacement only, each.
    A4342Accessories for patient inserted indwelling intraurethral drainage device with valve, replacement only, each.
    Ureteral stent HCPCS codesHCPCSCovered
    C1875Stent, coated/covered, without delivery system.
    C2617Stent, non-coronary, temporary, without delivery system.
    Other related CPT procedure rangesCPT
    34701-34834Endovascular Repair of Abdominal Aorta and/or Iliac Arteries.
    45000-45999Colon and Rectum Surgery.
    50300Donor nephrectomy; from cadaver donor, unilateral or bilateral.
    50320Donor nephrectomy; open, from living donor.
    50323-50329Backbench preparation/reconstruction of renal allograft codes.
    50340Recipient nephrectomy (separate procedure).
    50360-50370Renal allotransplantation implantation / removal.
    50400-50547Pyeloplasty and related renal procedures.
    50575-50590Renal endoscopy / lithotripsy codes.
    50740-50800Ureteral/bladder reconstructive procedure codes.
    1–10 of 13
    1/2
    ICD-10 diagnosis codesICD-10Covered
    N31.0-N31.9Neuromuscular dysfunction of bladder, not elsewhere classified.
    N32.81Overactive bladder [impaired detrusor contractility].
    N32.89Other specified disorders of bladder.
    N39.3-N39.498Stress and other specified urinary incontinence [expected to be 3 months duration or more].
    R32Unspecified urinary incontinence [expected to be 3 months duration or more].
    R33.0-R33.9Retention of urine [expected to be 3 months duration or more].
    R39.14Feeling of incomplete bladder emptying.
    C64.1-C64.9Malignant neoplasm of kidney, except renal pelvis.
    C65.1-C65.9Malignant neoplasm of renal pelvis.
    C66.1-C66.9Malignant neoplasm of ureter.
    1–10 of 15
    1/2
    Duration expectation for incontinence/retention diagnoses
    ExpectationIncontinence and retention ICD-10 diagnoses listed (eg, N39.3–N39.498, R32, R33.0–R33.9) are expected to be of 3 months’ duration or more to meet coverage selection criteria.
    Applicable codesExamples include N39.3–N39.498 (stress and other specified urinary incontinence), R32 (unspecified urinary incontinence), and R33.0–R33.9 (retention of urine).
    DocumentationMedical record must document that the condition is permanent or not expected to be corrected within 3 months to justify device/supply coverage.
    Intermittent catheter and lubricant per month
    Monthly maximum

    Provider Actions, Documentation, and Authorization

    Prior Authorization

    Obtain and document a complete Standard Written Order (SWO) before billing

    A completed Standard Written Order (SWO) must be communicated to the supplier before a claim is submitted; if the supplier bills without first receiving a completed SWO the claim will be denied as not medically necessary. The SWO must include member ID, order date, item description (HCPCS code or brand/model), separately listed options/accessories/supplies with HCPCS codes and quantities, treating practitioner name, NPI and signature.

    • SWO elements required: member name/ID; order date; description (HCPCS code, narrative, or brand/model); each concurrently ordered option/accessory/supply listed separately with HCPCS code and quantity; treating practitioner name and NPI; practitioner signature.
    • A new prescription from the treating practitioner is required each time a new device or repair is requisitioned.
    Prior Authorization

    Document selection criteria for specific supplies/devices (prior review likely)

    Certain specialized supplies and devices are covered only when documented selection criteria are met and therefore are likely subject to prior review; examples include three‑way Foley catheters for continuous irrigation (A4346), irrigation tubing sets (A4355), ureteral stents (C1875, C2617) and the inFlow device (CPT 0596T/0597T and HCPCS A4341/A4342).

    Background

    Background: Urinary catheters and external urinary collection devices are regarded as prosthetic devices for members with permanent urinary incontinence or permanent urinary retention (retention not expected to be corrected within 3 months). Coverage, quantity limits, and documentation requirements are applied accordingly to ensure supplies and devices are medically necessary for the member’s condition.

    Definitions

    Permanent urinary retention
    DefinitionPermanent urinary retention: retention not expected to be medically or surgically corrected in that person within 3 months.
    Coverage implicationPermanent retention status is a qualifying condition for urinary catheters and external urinary collection devices as prosthetics.
    ExamplesRetained urine diagnoses (eg, R33.x) are included among ICD‑10 codes expected to be 3 months’ duration or more per policy coding tables.
    External urinary collection devices
    Included devicesExternal urinary collection devices include male external catheters (condom type) and female pouches or meatal cups.
    ExclusionsThis term does not include diapers or other absorptive pads, which are not considered external urinary collection devices under this policy.
    Policy Summary
    PayerAetna
    PolicyUrological supplies (catheters and external urinary collection devices)
    Policy CodePolicy 0533
    Change TypeRoutine review — no material changes
    Effective DateAug 21, 2001
    Last ReviewJun 10, 2027
    Next Review DateJun 10, 2027
    Key ActionProvide a completed Standard Written Order (SWO) to the supplier before submitting a claim.
    SourceLink
    On This Page
    Coverage Criteria for Urological SuppliesCoding: HCPCS, CPT, and Diagnosis CodesProvider Actions, Documentation, and AuthorizationBackgroundDefinitions

    Policy notes PureWick as unproven/not medically necessary in some statements; consider program‑specific stance when adjudicating claims.

    Up to 200 intermittent catheters and/or sterile lubricant packets per month (per DME MAC–consistent limits).
    Included itemsApplies to straight and coude intermittent catheters (A4351–A4353; A4295–A4297) and lubricant sterile packets (A4332) as specified in policy tables.
    Per‑episode allowanceOne intermittent catheter with insertion supplies is considered medically necessary per episode of sterile intermittent catheterization.
    Lubricating gel limit for CIC
    Monthly limitMaximum 8 ounces of non‑sterile lubricating gel per month for clean intermittent catheterization (HCPCS A4402).
    Sterile packetsIndividual sterile lubricant packets (A4332) are noted as not medically necessary for CIC when billed for that indication.
    Use contextNon‑sterile gel limit applies for CIC; sterile lubricant packets have separate coverage considerations in policy.
    Tape maximum
    Monthly maximumMaximum 5 yards of tape per month (A4450/A4452) included with male external catheters that use adhesive strips or adhesive coating.
    InclusionAdhesive strips/tape are included in the allowance for male external catheter codes and are not separately payable.
    Tape typesPolicy references both non‑waterproof (A4450) and waterproof (A4452) tape allowances with the same monthly maximum.
    inFlow replacement interval
    Replacement intervalinFlow device is replaced every 29 days (essentially monthly).
    InsertionDevice sizing and initial insertion are performed by a physician; CPT 0596T used for initial insertion and 0597T for replacement.
    Re‑evaluationContinued medical necessity beyond the first 3 months requires re‑evaluation between day 31 and day 91 documenting benefit and adherence.
    PureWick wick replacement
    Wick replacement frequencyPureWick disposable wick must be replaced every 8–12 hours or sooner if soiled with feces or blood.
    System componentsSystem includes a disposable wick attached to a continuous low‑pressure pump and sealed collection canister.
    Use settingDescribed for external female urine collection, including nocturnal home use in comparative trial data.
    • A4346 (three‑way Foley for continuous irrigation) — coverage only when continuous irrigation is medically necessary.
    • A4355 (irrigation tubing set) — see quantity limits and clinical criteria.
    • Ureteral stent codes C1875 and C2617 — covered only if selection criteria are met.
    • inFlow device codes 0596T/0597T and A4341/A4342 — covered only when selection criteria documented.
    Prior Authorization

    Prior authorization/document clinical criteria for select device/procedure codes

    Certain procedure and device codes are listed as covered only if selection criteria are met and therefore require documentation of clinical selection criteria and may require prior authorization (examples include CPT 0596T/0597T and HCPCS A4341/A4342 for the inFlow device, and ureteral stent codes C1875/C2617).

    • 0596T / 0597T — inFlow initial insertion and replacement: document indication (e.g., impaired detrusor contractility, retention) and selection criteria.
    • A4341 / A4342 — inFlow related HCPCS: replacement/accessories require documented selection criteria.
    • C1875 / C2617 — ureteral stents require documented clinical indication per policy.
    Note

    Check appendix items — prior‑auth requirements not specified in excerpt

    The policy appendix lists numerous urological supply items (insertion trays, drainage bags, extension tubing, leg straps, lubricants, indwelling catheters, etc.); the excerpt does not specify explicit prior authorization requirements for each listed Appendix item, so verify payor-specific prior‑auth rules as needed.

    • Appendix includes insertion trays with/without drainage bag, bedside drainage bags, extension tubing, lubricant packets, leg straps and related items.
    • Explicit prior authorization requirements for these appendix items are not stated in the provided excerpt.
    Step Therapy

    Perform and document in‑person re‑evaluation for inFlow between day 31–91

    For continued coverage of the inFlow device beyond the first 3 months, the treating practitioner must perform and document a clinical re‑evaluation between day 31 and day 91 after initiating therapy showing (1) an in‑person encounter documenting improved urinary symptoms and (2) verification of member adherence to device use; if these are not met continued use is not medically necessary.

    • Re‑evaluation window: no sooner than day 31 and no later than day 91 after initiation.
    • Documentation must show in‑person encounter with symptom improvement and practitioner verification of adherence.
    • If re‑evaluation occurs after day 91 but documents benefit, coverage resumes from the date of that re‑evaluation.
    Note

    Document use of external collection devices as alternatives to indwelling catheters

    Consider documented alternatives to indwelling catheters for members with permanent incontinence; external collection devices (HCPCS A4326, A4327, A4328, A4349) are indicated as alternatives and should be selected and documented when clinically appropriate.

    • A4326, A4327, A4328, A4349 — external collection devices as alternatives to indwelling catheters for permanent incontinence.
    • Document rationale for choosing an external device instead of an indwelling catheter and adhere to quantity limits (e.g., A4349 maximum 35 per month).
    Documentation Required

    Document prior therapies and rationale when sequencing to inFlow

    When ordering the inFlow device, document prior therapies and rationale (for example prior trial of CIC and its tolerability) because clinical trial evidence compares inFlow to clean intermittent catheterization; the medical record should show prior therapy and reasons for choosing inFlow.

    • Document prior management such as CIC and trial tolerability (e.g., 1‑week tolerability trial described in studies).
    • Record clinical rationale for device selection and any contraindications to alternative therapies.
    Note

    No additional step‑therapy requirements specified in excerpt

    No step therapy or formal sequencing rules are specified in the provided excerpt; do not assume additional step‑therapy requirements beyond those explicitly stated for specific devices (e.g., inFlow re‑evaluation).

    • The excerpt explicitly states no step therapy requirements or sequencing rules are specified.
    • Follow device‑specific documentation/re‑evaluation requirements where present.
    Documentation Required

    Maintain complete medical record and SWO content to support coverage

    Medical records must contain sufficient information demonstrating that all applicable coverage criteria are met; supplier‑prepared statements or attestations alone are insufficient. Ensure the record includes clinical indications, prior therapy, device sizing/insertion notes (when applicable), and a new practitioner prescription for each new device or repair.

    • Supplier or financially interested records are not sufficient by themselves to support medical necessity.
    • Forms or supplier statements must be corroborated by information in the member’s medical record.
    • A new prescription is required each time a new device or repair is requisitioned.
    Documentation Required

    Document qualifying ICD‑10 diagnosis and support for billed codes

    Document the specific ICD‑10 diagnosis(es) that qualify for coverage (examples include N31.x neuromuscular dysfunction of bladder, N32.81 impaired detrusor contractility, R33.x retention, and incontinence codes expected to be of 3 months’ duration); the medical record must support the billed ICD‑10 and HCPCS/CPT codes.

    • Record one of the policy‑listed diagnoses when billing related supply/device codes (e.g., N32.81, R33.0‑R33.9, N31.0‑N31.9, R32).
    • Document expected duration (e.g., incontinence/retention diagnoses expected to be ≥3 months) where applicable.
    Documentation Required

    Support billed codes with medical record documentation

    Ensure the medical record supports the clinical rationale for each billed HCPCS/CPT code (selection criteria, indication, and quantity limits); supplier statements alone are insufficient and coverage depends on documentation corroborating the order and clinical need.

    • Corroborate supplier orders with clinical notes showing indication, prior therapies, and expected duration.
    • Include device sizing/insertion details for physician‑performed procedures (e.g., inFlow initial insertion).
    Note

    Providers must follow plan provisions and verify benefits

    Providers are responsible for the medical advice and treatment they provide and must follow plan benefits and program provisions referenced by Aetna; the Clinical Policy Bulletin is a summary and does not replace plan provisions.

    • The bulletin is a partial description of benefits and is not a contract or guarantee of coverage.
    • Providers should verify plan‑specific provisions when ordering supplies/devices.
    Denial Risk

    Failure to provide SWO before billing will result in denial

    If the supplier bills for an item addressed in this policy without first receiving a completed SWO, the claim shall be denied as not medically necessary.

    • Suppliers expected to stop billing if device use is discontinued.
    • Ensure SWO transmitted to supplier before claim submission to avoid denial.
    Denial Risk

    Billing not‑covered HCPCS codes for excluded indications may be denied

    HCPCS codes listed as not covered for indications in this bulletin (examples include A4245, A4247, A4318, A4321, A4335 and others) may trigger denials when billed for excluded indications; verify that the indication billed is permitted under policy.

    • Review the policy’s not‑covered/exclusion lists before billing these HCPCS codes.
    • Document clinical justification if an otherwise listed code is being requested for a covered indication.
    Billing Rule

    Certain supply codes (eg, A4332) are non‑covered for specific indications

    Use of certain supply codes is specifically noted as not medically necessary for particular indications (for example A4332: lubricant individual sterile packet is 'not medically necessary for CIC'); billing these supplies for excluded indications may result in denial.

    • A4332 — not medically necessary for clean intermittent catheterization (CIC).
    • Ensure lubricant and supply quantities conform to policy limits (e.g., A4402 non‑sterile gel max 8 oz/month for CIC).
    Denial Risk

    No additional explicit denial triggers stated in excerpt — corroborate documentation

    This excerpt does not present explicit administrative denial triggers beyond the SWO and not‑covered lists; the Clinical Policy Bulletin is informational and does not guarantee coverage decisions — always corroborate documentation against policy criteria.

    • Administrative statements emphasize the bulletin is not exhaustive and may be updated.
    • Absence of an explicit denial trigger in the excerpt does not replace case‑level documentation requirements.
    Quantity guidanceMale external catheters generally limited to no more than 35 per month; adhesive strips/tape included in code allowance.
    Meatal cup
    DescriptionMeatal cup: a plastic cup held in place around the female urethra by suction or pressure and connected to a urinary drainage container (bag or bottle).
    FunctionDesigned to collect urine externally from female urethra and drain to a collection container; considered a type of female external collection device.
    Quantity notePolicy indicates more than 1 meatal cup per week is not considered medically necessary for female external devices.
    Continuous catheter irrigation
    DefinitionContinuous catheter irrigation: use of a three‑way Foley catheter with an irrigation tubing set to provide ongoing bladder irrigation (eg, A4346 with A4355).
    Examples/codesExamples include three‑way Foley (A4346) and irrigation tubing set for continuous bladder irrigation (A4355).
    Quantity/durationIrrigation tubing A4355 limited to 1 per day, up to 2 weeks total; continuous irrigation >2 weeks is rarely medically necessary.
    Intermittent catheterization (CIC)
    DefinitionIntermittent catheterization (CIC): periodic bladder catheterizations using single‑use or hydrophilic intermittent urinary catheters with insertion supplies (eg, A4351–A4353, A4295–A4297).
    Examples/codesRelevant HCPCS codes include A4351, A4352, A4353, A4295–A4297 (straight and coude intermittent catheters and hydrophilic variants).
    Per‑episode noteOne intermittent catheter with insertion supplies is considered medically necessary per episode of medically necessary sterile intermittent catheterization.
    Sterile intermittent catheterization
    DefinitionSterile intermittent catheterization: use of a new sterile packaged catheter and sterile lubricant for each catheterization; may include sterile gloves, drape, and antiseptic peri‑urethral cleansing.
    When coveredSterile intermittent catheterization is covered when the member requires catheterization and meets specified clinical criteria (eg, immunosuppression, nursing facility residence, documented reflux on program).
    SuppliesSterile insertion supplies are allowed per episode; policy tables list related HCPCS and per‑month limits consistent with DME MAC guidance.
    Clean intermittent catheterization
    DefinitionClean intermittent catheterization: use of soap and water for peri‑urethral cleansing with a reusable catheter cleansed between episodes and non‑sterile lubricant.
    Not covered itemsCatheter insertion trays are of no proven benefit for clean, non‑sterile CIC and are not considered medically necessary for that technique.
    Lubricant guidanceUse of certain individual sterile lubricant packets (A4332) is not medically necessary for CIC; non‑sterile gel limits apply (A4402).
    inFlow device
    Device definitioninFlow device: a sterile, single‑use intra‑urethral valve‑pump prosthesis for women with impaired detrusor contractility that is inserted by a physician and replaced every 29 days.
    Components/useSystem includes the inFlow device and the Activator (hand‑held remote); device insertion is similar to catheter insertion and sizing/initial insertion is physician‑performed.
    Coding/replaceProcedure codes: CPT 0596T (initial insertion) and 0597T (replacement); replacement interval is 29 days per policy.
    PureWick system
    System definitionPureWick system: an external female urine collection system comprising a flexible disposable ‘wick’ attached to a low‑pressure pump that pulls urine into a sealed collection canister.
    Wick managementThe disposable wick is replaced every 8–12 hours or sooner if soiled with feces or blood.
    Intended useDesigned as a noninvasive external urine collection option for female patients to manage incontinence and potentially reduce indwelling catheter use.
    Absorbable urologic scaffold (Voro)
    DefinitionAbsorbable urologic scaffold (Voro): a temporary, fully absorbable scaffold implanted intraoperatively during robot‑assisted radical prostatectomy (RARP) to support the bladder neck/urethral anastomosis and potentially reduce early post‑operative stress urinary incontinence.
    Clinical evidenceEarly feasibility single‑arm data (ARID study) report favorable early continence outcomes among 24 evaluable patients but lack randomized data and long‑term follow‑up.
    Procedure codingListed as CPT/HCPCS related (eg, 1042T as implantation of absorbable urologic scaffold) and considered investigational/conditional pending stronger evidence.